Real-time enrollment status for this iga nephropathy clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT06291376 |
| Recruiting Status | Recruiting |
| Condition | IgA Nephropathy |
| Phase | Clinical Trial |
| Target Enrollment | 510 participants |
| Active Locations | 49 sites in the US |
| Sponsor | Alexion Pharmaceuticals, Inc. |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT06291376 is currently recruiting participants. This clinical trial study for iga nephropathy is actively seeking new participants at 49 locations across the United States. The study is sponsored by Alexion Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06291376 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 49 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06291376 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.